SangYun Kim Selected Research

SangYun Kim Research Topics

Disease

62	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 01/2011
28	Cognitive Dysfunction 02/2024 - 03/2015
25	Dementia (Dementias) 11/2023 - 06/2011
14	Atrophy 10/2022 - 01/2017
7	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 01/2016
6	Disease Progression 01/2021 - 01/2017
5	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2019 - 09/2014
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2016
3	Normal Pressure Hydrocephalus 02/2024 - 03/2018
3	Amyloid Plaque 01/2024 - 01/2022
3	Frontotemporal Dementia (Semantic Dementia) 01/2023 - 06/2011
3	Infections 01/2022 - 11/2020
2	Inflammation (Inflammations) 01/2018 - 05/2017
2	Brain Diseases (Brain Disorder) 01/2018 - 09/2004
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2018 - 01/2016
2	Sporadic Creutzfeldt-Jakob Disease 01/2016 - 09/2014
1	Spastic ataxia Charlevoix-Saguenay type 12/2023
1	Spastic Ataxia 12/2023
1	Synucleinopathies 12/2022
1	Hypertension (High Blood Pressure) 10/2022
1	Hypothyroidism 01/2022
1	Neuroblastoma 01/2022
1	Genetic Risk Score 01/2021
1	Body Weight (Weight, Body) 01/2021
1	COVID-19 11/2020
1	Neoplasms (Cancer) 06/2020
1	Edema (Dropsy) 06/2020
1	Hypersensitivity (Allergy) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	REM Sleep Behavior Disorder 01/2019
1	Anorexia 01/2019
1	Nausea 01/2019

Drug/Important Bio-Agent (IBA)

28	Amyloid (Amyloid Fibrils)IBA 02/2024 - 07/2015
27	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2016
9	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2011
8	Apolipoproteins E (ApoE)IBA 06/2022 - 01/2014
6	Amyloid beta-PeptidesIBA 02/2024 - 06/2018
6	Donepezil (Aricept)FDA LinkGeneric 07/2021 - 01/2011
5	Presenilin-1IBA 10/2021 - 01/2017
5	Pemetrexed (MTA)FDA Link 06/2020 - 01/2017
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021 - 01/2017
3	EnzymesIBA 01/2023 - 07/2015
3	Presenilin-2IBA 11/2022 - 01/2015
3	ApolipoproteinsIBA 10/2022 - 01/2014
3	PrionsIBA 01/2019 - 01/2018
2	Complement System Proteins (Complement)IBA 02/2024 - 01/2022
2	Agent OrangeIBA 04/2023 - 06/2018
2	Leucine (L-Leucine)FDA Link 11/2022 - 05/2014
2	SynucleinsIBA 01/2021 - 01/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2021 - 01/2019
2	AcetylcholinesteraseIBA 01/2021 - 01/2021
2	ORALIT (ORS)IBA 06/2020 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2010
2	Prion ProteinsIBA 01/2018 - 01/2016
2	Rivastigmine (Exelon)FDA LinkGeneric 10/2017 - 01/2017
1	Complement C3 (C3 Complement)IBA 02/2024
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2024
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2024
1	Fluorine-18IBA 01/2024
1	Molecular Chaperones (Chaperone, Molecular)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 11/2023
1	FPS-ZM1IBA 01/2023
1	alpha-SynucleinIBA 12/2022
1	Heparin (Liquaemin)FDA LinkGeneric 11/2022
1	Phosphotransferases (Kinase)IBA 11/2022
1	Notch ReceptorsIBA 11/2022
1	Adenosine Triphosphate (ATP)IBA 11/2022
1	Hormones (Hormone)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2022
1	ElementsIBA 01/2022
1	mirodenafilIBA 01/2022
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	CateninsIBA 01/2022
1	sharpinIBA 11/2021
1	Vitamin D FDA LinkGeneric 08/2021
1	hydroxide ionIBA 08/2021
1	Ginkgo biloba extract (Rokan)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Chitinase-3-Like Protein 1IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	ChitinasesIBA 01/2021
1	AD 11IBA 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2020
1	Alanine (L-Alanine)FDA Link 12/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2018
1	Glycerylphosphorylcholine (Choline Alfoscerate)IBA 06/2018
1	Cyproterone AcetateIBA 02/2018

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2003
4	Activities of Daily Living (ADL) 11/2020 - 06/2011
1	Wearable Electronic Devices 01/2024
1	Lab-On-A-Chip Devices 01/2023
1	Institutionalization (Institutionalized Persons) 06/2020
1	Cognitive Training 10/2018
1	Cerebrospinal Fluid Shunts 03/2018